NCT04929028 2026-03-18
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Zhejiang University
OHSU Knight Cancer Institute
Sorlandet Hospital HF
Emory University
Dartmouth-Hitchcock Medical Center
Institut Investigacio Sanitaria Pere Virgili
Persephone Biosciences
South Tyneside and Sunderland NHS Foundation Trust